Phio Pharmaceuticals Corp... (PHIO)
Phio Pharmaceuticals Statistics
Share Statistics
Phio Pharmaceuticals has 4.78M shares outstanding. The number of shares has increased by -29.1% in one year.
| Shares Outstanding | 4.78M |
| Shares Change (YoY) | -29.1% |
| Shares Change (QoQ) | 101.27% |
| Owned by Institutions (%) | 4.22% |
| Shares Floating | 4.23M |
| Failed to Deliver (FTD) Shares | 33.73K |
| FTD / Avg. Volume | 0.51% |
Short Selling Information
The latest short interest is 51.49K, so 1.08% of the outstanding shares have been sold short.
| Short Interest | 51.49K |
| Short % of Shares Out | 1.08% |
| Short % of Float | 1.58% |
| Short Ratio (days to cover) | 0.5 |
Valuation Ratios
The PE ratio is -0.15 and the forward PE ratio is 0.07. Phio Pharmaceuticals's PEG ratio is 0.
| PE Ratio | -0.15 |
| Forward PE | 0.07 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 0.2 |
| P/FCF Ratio | -0.15 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Phio Pharmaceuticals Corp..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.71, with a Debt / Equity ratio of 0.
| Current Ratio | 5.71 |
| Quick Ratio | 5.71 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0.45 |
| Cash Flow / Debt | -307.11 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -1.4% and return on capital (ROIC) is -139.39%.
| Return on Equity (ROE) | -1.4% |
| Return on Assets (ROA) | -1.16% |
| Return on Capital (ROIC) | -139.39% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -1.35M |
| Employee Count | 8 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -83.64% in the last 52 weeks. The beta is 1.53, so Phio Pharmaceuticals's price volatility has been higher than the market average.
| Beta | 1.53 |
| 52-Week Price Change | -83.64% |
| 50-Day Moving Average | 2.14 |
| 200-Day Moving Average | 3.53 |
| Relative Strength Index (RSI) | 37.86 |
| Average Volume (20 Days) | 6.58M |
Income Statement
| Revenue | n/a |
| Gross Profit | -6.33M |
| Operating Income | -10.82M |
| Net Income | -10.83M |
| EBITDA | -10.64M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -46.87 |
Balance Sheet
The company has 8.49M in cash and 35K in debt, giving a net cash position of 8.46M.
| Cash & Cash Equivalents | 8.49M |
| Total Debt | 35K |
| Net Cash | 8.46M |
| Retained Earnings | -139.21M |
| Total Assets | 5.87M |
| Working Capital | 4.95M |
Cash Flow
In the last 12 months, operating cash flow was -10.75M and capital expenditures -5K, giving a free cash flow of -10.75M.
| Operating Cash Flow | -10.75M |
| Capital Expenditures | -5K |
| Free Cash Flow | -10.75M |
| FCF Per Share | -46.55 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PHIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -3324.11% |
| FCF Yield | -159.66% |
Analyst Forecast
The average price target for PHIO is $4, which is 183.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $4 |
| Price Target Difference | 183.7% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Jul 5, 2024. It was a backward split with a ratio of 1:9.
| Last Split Date | Jul 5, 2024 |
| Split Type | backward |
| Split Ratio | 1:9 |
Scores
| Altman Z-Score | -33.09 |
| Piotroski F-Score | 2 |